Robert Duggan (Kelly Morfopoulos via Wikimedia)

With Covid-19 muck­ing the tires, Robert Dug­gan throws an­oth­er $50M be­hind his big an­tibi­otics play

Robert Dug­gan is up­ping his ante on Sum­mit Ther­a­peu­tics.

The bil­lion­aire in­vestor qui­et­ly bid up to 65% of the small an­tibi­ot­ic de­vel­op­er be­fore

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.